TRINETRA › Sectors › Healthcare
Hexagon Nutrition Limited (HEXAGON) — share price, P/E and fundamentals
Hexagon Nutrition Limited (NSE: HEXAGON) closed at ₹54.11 on 30 Oct 2026, against a 52-week range of ₹48.10 – ₹78.25.
In the quarter ended 30 Jun 2026 (consolidated, filed 12 Aug 2026) it reported revenue of ₹104 cr and net profit of ₹8 cr, a 7.7% net margin.
No trailing P/E is published: only 2 filed quarters available — a trailing twelve months needs 4.
From the balance sheet dated 31 Mar 2026: return on equity 13.8%, ROCE 18.8%, debt-to-equity 0.13.
Against 66 Healthcare peers on NSE: Net margin higher than 19% of 64 sector peers; PBT margin higher than 16% of 64 sector peers; ROE higher than 48% of 64 sector peers.
Key figures
| Last close | ₹54.11 (30 Oct 2026) |
|---|---|
| Change 1 month / 6 months / 1 year | -16.5% / — / — |
| 52-week low – high | ₹48.10 – ₹78.25 |
| Market capitalisation | ₹665 cr |
| Quarter revenue | ₹104 cr |
| Quarter net profit | ₹8 cr |
| Net margin | 7.7% |
| Return on equity | 13.8% |
| ROCE | 18.8% |
| Debt / equity | 0.13 |
| Current ratio | 3.38 |
| Free cash flow | ₹-1 cr |
| Average daily turnover (50 days) | ₹1.9 cr |
Against Healthcare peers
| Metric | HEXAGON | Peer median | Percentile |
|---|---|---|---|
| Net margin | 7.74 | 12.89 | 19 |
| PBT margin | 10.16 | 17.68 | 16 |
| ROE | 13.84 | 13.87 | 48 |
| ROCE | 18.75 | 17.26 | 63 |
| Debt / equity | 0.13 | 0.11 | 54 |
| Cash conversion | 0.16 | 1.25 | 5 |
Questions
What were Hexagon Nutrition Limited's latest quarterly results?
For the quarter ended 30 Jun 2026, Hexagon Nutrition Limited reported revenue of ₹104 cr and net profit of ₹8 cr (consolidated), filed with the exchange on 12 Aug 2026.
What is Hexagon Nutrition Limited's ROE?
Return on equity is 13.8% based on the balance sheet dated 31 Mar 2026.
Does Hexagon Nutrition Limited have debt?
Debt-to-equity is 0.13 on the balance sheet dated 31 Mar 2026.
What is HEXAGON's 52-week high and low?
Over the last 52 weeks to 30 Oct 2026, HEXAGON traded between ₹48.10 and ₹78.25.
Other Healthcare stocks
- Sun Pharmaceutical Industries Limited (SUNPHARMA)
- Divi's Laboratories Limited (DIVISLAB)
- Torrent Pharmaceuticals Limited (TORNTPHARM)
- Laurus Labs Limited (LAURUSLABS)
- Zydus Lifesciences Limited (ZYDUSLIFE)
- Apollo Hospitals Enterprise Limited (APOLLOHOSP)
- Dr. Reddy's Laboratories Limited (DRREDDY)
- Cipla Limited (CIPLA)
- Mankind Pharma Limited (MANKIND)
- Aurobindo Pharma Limited (AUROPHARMA)
- Lupin Limited (LUPIN)
- Max Healthcare Institute Limited (MAXHEALTH)
Source: consolidated SEBI Integrated Filing for the quarter ended 30 Jun 2026 and NSE daily closes. Open the interactive terminal view for charts and the full statements.
TRINETRA is a research and education tool. Nothing on this site is investment advice or a recommendation to buy or sell any security. Markets carry risk; do your own research and consult a SEBI-registered adviser before investing. Figures are as filed with NSE/SEBI and as of the dates shown; they are not live prices.